- Home
- LNTH vs CBZ Comparison
LNTH vs CBZ Comparison
Compare LNTH & CBZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LNTH
- CBZ
- Stock Information
- Founded
- LNTH 1956
- CBZ 1987
- Country
- LNTH United States
- CBZ United States
- Employees
- LNTH N/A
- CBZ N/A
- Industry
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- CBZ Business Services
- Sector
- LNTH Health Care
- CBZ Consumer Discretionary
- Exchange
- LNTH Nasdaq
- CBZ Nasdaq
- Market Cap
- LNTH 3.6B
- CBZ 3.5B
- IPO Year
- LNTH 2015
- CBZ N/A
- Fundamental
- Price
- LNTH $52.94
- CBZ $55.70
- Analyst Decision
- LNTH Strong Buy
- CBZ
- Analyst Count
- LNTH 5
- CBZ 0
- Target Price
- LNTH $91.60
- CBZ N/A
- AVG Volume (30 Days)
- LNTH 1.5M
- CBZ 523.3K
- Earning Date
- LNTH 11-05-2025
- CBZ 10-28-2025
- Dividend Yield
- LNTH N/A
- CBZ N/A
- EPS Growth
- LNTH N/A
- CBZ N/A
- EPS
- LNTH 3.77
- CBZ 1.84
- Revenue
- LNTH $1,520,653,000.00
- CBZ $2,420,673,000.00
- Revenue This Year
- LNTH N/A
- CBZ $57.54
- Revenue Next Year
- LNTH $3.24
- CBZ $5.95
- P/E Ratio
- LNTH $14.03
- CBZ $30.24
- Revenue Growth
- LNTH 5.75
- CBZ 46.49
- 52 Week Low
- LNTH $47.25
- CBZ $55.59
- 52 Week High
- LNTH $118.21
- CBZ $90.13
- Technical
- Relative Strength Index (RSI)
- LNTH 38.79
- CBZ 30.82
- Support Level
- LNTH $51.94
- CBZ $55.59
- Resistance Level
- LNTH $55.24
- CBZ $58.17
- Average True Range (ATR)
- LNTH 1.97
- CBZ 1.82
- MACD
- LNTH 0.48
- CBZ -0.53
- Stochastic Oscillator
- LNTH 14.89
- CBZ 1.01
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
About CBZ CBIZ Inc.
CBIZ Inc through its subsidiaries provides professional services advisors to middle-market businesses and organizations nationwide. Its business units have been aggregated into three practice groups: Financial Services, Benefits and Insurance Services, and National Practices. The company provides its services to various industries such as Banking & Financial Services, Commercial Real Estate, Construction, Health Care Manufacturing & Distribution NFP & Education, Private Client Services, Professional Services, Public Sector, and Technology & Life Sciences. It derives the majority of its revenues from the Financial Services segment and geographically from the United States.